Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
JOHN HOLT PLC	JOHNHOLT	Nigerian S.E.	20,191	1.98 NGN	Stock
JOHN KEELLS PLC	JKL.N0000	Colombo S.E.	21,656	68.8 LKR	Stock
JOHN KEELLS HOTELS PLC	KHL.N0000	Colombo S.E.	376,043	19 LKR	Stock
JOHN MARSHALL BANCORP, INC.	JMSB	Nasdaq	13,122	17.25 USD	Stock
JOHN BEAN TECHNOLOGIES CORPORATION	JBT	Nyse +4 Other	261,778	93.55 USD	Stock
JOHN BEAN TECHNOLOGIES CORPORATION	JBT	Deutsche Boerse AG	-	85.5 EUR
JOHN BEAN TECHNOLOGIES CORPORATION	JBT	Börse Stuttgart	-	85.5 EUR
JOHN BEAN TECHNOLOGIES CORPORATION	JBT	BOERSE MUENCHEN	-	86.5 EUR
JOHN BEAN TECHNOLOGIES CORPORATION	JBT	Berne S.E.	-	- CHF
JOHN HANCOCK INVESTORS TRUST	JHI	Nyse	19,024	13.58 USD	Stock
JOHN COCKERILL INDIA LIMITED	COCKERILL	Bombay S.E.	10,501	3,887 INR	Stock
JOHN HANCOCK PREMIUM DIVIDEND FUND	PDT	Nyse	95,334	11.75 USD	Stock
JOHN HANCOCK PREFERRED INCOME FUND	HPI	Nyse	54,951	16.58 USD	Stock
JOHN HANCOCK FINANCIAL OPPORTUNITIES FUND	BTO	Nyse	38,944	28.83 USD	Stock

See all

News (159)

Transcript : Novavax, Inc., Q1 2024 Earnings Call, May 10, 2024	05-10
Transcript : Novavax, Inc., Q4 2023 Earnings Call, Feb 28, 2024	02-28
Transcript : Novavax, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 05:15 PM	01-08
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities	11-20	AQ
Novavax, Inc. Announces Changes to Executive Leadership Team	11-17	CI
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities	11-17	PR
Transcript : Novavax, Inc., Q3 2023 Earnings Call, Nov 09, 2023	11-09
Novavax to sell 7% stake to South Korea's SK Bioscience	23-08-08	RE
Transcript : Novavax, Inc., Q2 2023 Earnings Call, Aug 08, 2023	23-08-08
Novavax : Chief Corporate Affairs and Advocacy Officer Appointed to Maryland Tech Council Board	23-07-26	PU
Transcript : Novavax, Inc. Presents at Bank of America Securities 2023 Healthcare Conference, May-11-2023 10:00 AM	23-05-11
Transcript : Novavax, Inc., Q1 2023 Earnings Call, May 09, 2023	23-05-09
Transcript : Novavax, Inc. Presents at Cowen 43rd Annual Healthcare Conference, Mar-08-2023 09:50 AM	23-03-08
Novavax to Participate in TD Cowen's 43rd Annual Health Care Conference	23-03-06	PR
Transcript : Novavax, Inc., Q4 2022 Earnings Call, Feb 28, 2023	23-02-28
Transcript : Novavax, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 05:15 PM	23-01-09
Transcript : Novavax, Inc. Presents at Bank of America 2022 Virtual Biotech SMID Cap Conference, Dec-07-2022 09:10 AM	22-12-07
Novavax to Participate in BofA Securities 2022 Virtual Biotech SMID Cap Conference	22-12-05	AQ
Novavax to Participate in BofA Securities 2022 Virtual Biotech SMID Cap Conference	22-12-02	PR
Transcript : Novavax, Inc. Presents at 13th Annual Jefferies London Healthcare Conference 2022, Nov-16-2022 08:35 AM	22-11-16
Novavax to Participate in Jefferies London Healthcare Conference	22-11-14	PR
Transcript : Novavax, Inc., Q3 2022 Earnings Call, Nov 08, 2022	22-11-08
Analysis-Falling demand for COVID boosters puts price hikes on the table	22-10-20	RE
Transcript : Novavax, Inc. Presents at Baird 2022 Global Healthcare Conference, Sep-13-2022 08:30 AM	22-09-13
Transcript : Novavax, Inc. Presents at H.C. Wainwright 24th Annual Global Investment Conference, Sep-12-2022 04:00 PM	22-09-12
Novavax to Participate in Upcoming September Conferences	22-09-07	PR
Novavax to Participate in Fireside Chat at the SVB Securities Virtual Vaccine Forum	22-08-11	PR
Novavax tumbles 30% as waning COVID-19 vaccine demand hits outlook	22-08-09	RE
Transcript : Novavax, Inc., Q2 2022 Earnings Call, Aug 08, 2022	22-08-08
Novavax could ship COVID vaccine doses to U.S. by end of June	22-06-07	RE
Transcript : Novavax, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2022 05:20 PM	22-05-11
Novavax shares slide 20% on COVID vaccine demand uncertainty	22-05-10	RE
Transcript : Novavax, Inc., Q1 2022 Earnings Call, May 09, 2022	22-05-09
Novavax 2022 COVID vaccine deliveries off to slow start, shares drop	22-05-09	RE
Novavax to Participate in BofA Securities 2022 Healthcare Conference	22-05-04	PR
Novavax Announces Launch of Global Vaccine Education Programs	22-03-10	PR
Transcript : Novavax, Inc. Presents at 42nd Annual Cowen Health Care Conference, Mar-08-2022 09:50 AM	22-03-08
Novavax to Participate in Cowen's 42nd Annual Health Care Conference	22-03-02	PR
Transcript : Novavax, Inc., Q4 2021 Earnings Call, Feb 28, 2022	22-02-28
Canada approves Novavax's COVID-19 vaccine for adults	22-02-17	RE
Transcript : Novavax, Inc. Presents at 11th SVB Leerink Annual Global Healthcare Conference 2022, Feb-16-2022 11:20 AM	22-02-16
Novavax to Participate in Fireside Chat at the 11th Annual SVB Leerink Global Healthcare Conference	22-02-14	AQ
Novavax to Participate in Fireside Chat at the 11th Annual SVB Leerink Global Healthcare Conference	22-02-11	PR
Transcript : Novavax, Inc. - Special Call	22-02-10
Transcript : Novavax, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 09:00 AM	22-01-10

1234NextSee all

Companies (91)

WATSCO, INC. 17 761 M $

Watsco, Inc. is engaged in the distribution of air conditioning, heating and refrigeration equipment and related parts and supplies (HVAC/R) with locations in the United States, Canada, Mexico, and Puerto Rico, and on an export basis to Latin America and ...

WATSCO, INC. 17 761 M $

MANULIFE FINANCIAL CORPORATION 47 962 M $

Manulife Financial Corporation is a Canada-based international financial services company. The Company operates as Manulife across its offices in Asia, Canada, and Europe, and primarily as John Hancock in the United States. It provides financial advice, i ...

MANULIFE FINANCIAL CORPORATION 47 962 M $

JOHN KEELLS PLC 14 M $

John Keells PLC is a Sri Lanka-based company, which produces broking services. The Company is engaged in the provision of tea and rubber broking services. The Company operates through three segments: Produce Broking, Warehousing and Stock Broking. The Pro ...

1234Next

Insiders

John Trizzino

Mr. John J. Trizzino is a CFO, EVP, Chief Commercial & Business Officer at Novavax, Inc. Mr. Trizzino was previously employed as a Chief Executive Officer & Director by ImmunoVaccine, Inc., a Vice President-Vaccine Franchise by MedImmune LLC, a Vice President-Business Development by ID Biomedical Corp., and a Vice President-Business Development by Henry Schein, Inc. He also served on the board at Tech Council of Maryland, Inc. He received his undergraduate degree from Long Island University and an MBA from The Leonard N Stern School of Business.

Victor F. Trizzino

Victor F.
Trizzino is currently the Vice President at Valiant Solutions, Inc. He was previously the President & Chief Executive Officer at Standard Microsystems Corp.
from 1980 to 1995.
He also served as an Independent Director at American Defense Systems, Inc. from 2011 to 2012.
Trizzino received his undergraduate degree from Iona College and his MBA from St. John's University.

Gaspare Trizzino

Gaspare Trizzino currently holds the position of President at Istituti Clinici Zucchi SpA.

Peter Trizzino

No results for this search